Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392.SSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
314
Cost of Revenue
121
Gross Profit
193
Gross Margin
61.4%
Operating Income
13
Operating Margin
4.2%
Net Income
15
Net Margin
4.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-9
EBITDA Margin
-2.9%
2023
12/31/2023
Revenue
772
Cost of Revenue
152
Gross Profit
620
Gross Margin
80.3%
Operating Income
196
Operating Margin
25.4%
Net Income
175
Net Margin
22.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
221
EBITDA Margin
28.7%
2022
12/31/2022
Revenue
1,566
Cost of Revenue
168
Gross Profit
1,398
Gross Margin
89.3%
Operating Income
783
Operating Margin
50.0%
Net Income
663
Net Margin
42.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
756
EBITDA Margin
48.3%
2021
12/31/2021
Revenue
805
Cost of Revenue
119
Gross Profit
686
Gross Margin
85.2%
Operating Income
326
Operating Margin
40.5%
Net Income
283
Net Margin
35.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
327
EBITDA Margin
40.6%
2020
12/31/2020
Revenue
330
Cost of Revenue
66
Gross Profit
263
Gross Margin
79.9%
Operating Income
109
Operating Margin
32.9%
Net Income
95
Net Margin
28.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
113
EBITDA Margin
34.4%